IRHO

IRHO is not an operating business — it's a blank-check shell. The MD&A states plainly: 'We have neither engaged in any operations nor generated any revenues to date,' and the FY2025 net loss of $204K is nothing but G&A burn from being a public company. The FY2025 balance sheet (cash of $432, negative equity of -$174K, a $512,915 working-capital deficit) reflects the pre-IPO organizational stub and is economically irrelevant now. The real story is the subsequent event: on December 18, 2025 the company closed its IPO of 23,000,000 units at $10.00 (full over-allotment) plus 570,000 private-placement units, placing $230,000,000 into a Trust Account invested in short-dated Treasuries / 2a-7 money funds.

That trust is the whole valuation. At $10.05 the stock sits a few cents above the ~$10.00 per-unit trust value, so a buyer is paying a small premium for a redemption-backed claim on cash. The filing spells out the downside floor: shareholders can redeem their shares for their pro-rata trust amount either in a vote or if no business combination is consummated within 24 months of the IPO. Practically, this behaves like a Treasury bill wrapped in an equity ticker — limited downside to trust, and the small premium is the cost of the embedded warrant/deal optionality.